Company Alopexx, Inc.
Equities
ALPX
US02052J1016
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Gerald B. Pier
FOU | Founder | 72 | 22/03/19 |
Daniel R. Vlock
CEO | Chief Executive Officer | 72 | 22/03/19 |
Thomas T. Thomas
DFI | Director of Finance/CFO | 66 | 31/07/21 |
Corporate Officer/Principal | 70 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Werth
BRD | Director/Board Member | 85 | - |
Ann MacDougall
BRD | Director/Board Member | 70 | - |
Richard Cohen
BRD | Director/Board Member | 73 | - |
William Chin
BRD | Director/Board Member | 76 | - |
Daniel R. Vlock
CEO | Chief Executive Officer | 72 | 22/03/19 |
Gail H. Cassell
BRD | Director/Board Member | 77 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 7,847,178 | 0 | 0 | - |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B | |
-6.26% | 11.42B |